4351 - 4375 of 9145 Results
Title
Year
- Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease2010RESTRICTEDTitle: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1367Issue #:Start Page: 310End Page: 318Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099Citation Count: 47
-
RESTRICTEDTitle: Age-related changes in glutathione and glutathione-related enzymes in rat brainJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1090Issue #: 1Start Page: 35End Page: 44Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2006.03.063Best OA location URL: http://doi.org/10.1016/j.brainres.2006.03.063Citation Count: 278
-
OPENTitle: Personalized care management for persons with Parkinson's disease: A telenursing solutionJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 3Issue #:Start Page: 100070End Page: 100070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100070Best OA location URL: https://doi.org/10.1016/j.prdoa.2020.100070Citation Count: 11
-
OPENTitle: MPP+‐dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neuronsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 169Issue #: 1Start Page: 130End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.12104Citation Count: 29
-
OPENTitle: Myelin Basic Protein-primed T Cells Induce Neurotrophins in Glial Cells via α5β3 IntegrinJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 282Issue #: 44Start Page: 32222End Page: 32232Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m702899200Best OA location URL: https://doi.org/10.1074/jbc.m702899200Citation Count: 37
-
OPENTitle: The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 51Issue #: 2Start Page: 345End Page: 356Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-150859Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6074044Citation Count: 96
-
OPENTitle: Select E2 enzymes differentially regulate parkin activation and mitophagyJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol:Issue #:Start Page: 3488End Page: 504Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/jcs.147520Best OA location URL: http://doi.org/10.1242/jcs.147520Citation Count: 70
- Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging2016OPENTitle: Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of AgingJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 65Issue #: 4Start Page: 792End Page: 799Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jgs.14670Best OA location URL: http://doi.org/10.1111/jgs.14670Citation Count: 63
-
OPENTitle: Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed ActivationJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 64Issue #: 2Start Page: 597End Page: 606Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-180121Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6518401Citation Count: 101
-
OPENTitle: Stem cells in development of therapeutics for Parkinson's disease: A perspectiveJournal Name: Journal of Cellular BiochemistryPublisher: WileyVol: 105Issue #: 5Start Page: 1153End Page: 1160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jcb.21916Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcb.21916Citation Count: 15
- Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease2010OPENTitle: Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 120Issue #: 8Start Page: 2745End Page: 2754Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci42642Best OA location URL: http://www.jci.org/articles/view/42642/files/pdfCitation Count: 420
-
OPENTitle: Metabolic network expression in parkinsonism: Clinical and dopaminergic correlationsJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 37Issue #: 2Start Page: 683End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/0271678x16637880Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X16637880Citation Count: 63
- Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion2011RESTRICTEDTitle: Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusionJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 124Issue #: 9Start Page: 1403End Page: 1410Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1242/jcs.079293Citation Count: 77
-
OPENTitle: Heterogeneity of Cholinergic Denervation in Parkinson's Disease without DementiaJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 32Issue #: 8Start Page: 1609End Page: 1617Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/jcbfm.2012.60Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2012.60Citation Count: 186
-
OPENTitle: Neuroimmunology of the Interleukins 13 and 4Journal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 2Start Page: 18End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6020018Best OA location URL: https://www.mdpi.com/2076-3425/6/2/18/pdf?version=1465804812Citation Count: 126
- Serum lipid alterations in GBA-associated Parkinson's disease2017RESTRICTEDTitle: Serum lipid alterations in GBA-associated Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 58End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.026Citation Count: 90
-
OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 70
-
OPENTitle: Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 8Issue #: 3Start Page: 321End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.14Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3815586Citation Count: 54
-
OPENTitle: DAT-SPECT-based subtype and stage inference in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-026-01347-2Best OA location URL: https://www.nature.com/articles/s41531-026-01347-2_reference.pdfCitation Count: 1
-
OPENTitle: Orientation selective deep brain stimulationJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 14Issue #: 1Start Page: 016016End Page: 016016Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1088/1741-2552/aa5238Best OA location URL: http://doi.org/10.1088/1741-2552/aa5238Citation Count: 51
-
OPENTitle: Beliefs About Use of Complementary Health Approaches for Parkinson's DiseaseJournal Name: Holistic Nursing PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 5Start Page: 290End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5664950Citation Count: 0
-
OPENTitle: Parkinson's disease prevalence in Fabry disease: A survey studyJournal Name: Molecular Genetics and Metabolism ReportsPublisher: Elsevier BVVol: 14Issue #:Start Page: 27End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymgmr.2017.10.013Best OA location URL: https://doi.org/10.1016/j.ymgmr.2017.10.013Citation Count: 39
- Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation2018RESTRICTEDTitle: Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulationJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 390Issue #:Start Page: 33End Page: 35Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.04.002Citation Count: 2
-
OPENTitle: Genetic Testing for Parkinson DiseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 1Start Page: 69End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000831Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8101316Citation Count: 39
- Balance Testing With Inertial Sensors in Patients With Parkinson's Disease: Assessment of Motor Subtypes2014RESTRICTEDTitle: Balance Testing With Inertial Sensors in Patients With Parkinson's Disease: Assessment of Motor SubtypesJournal Name: IEEE Transactions on Neural Systems and Rehabilitation EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 22Issue #: 5Start Page: 1064End Page: 1071Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/tnsre.2013.2292496Citation Count: 42